Imugene Limited

IUGNF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$20,683-$48,339-$80,966-$68,715
Dep. & Amort.$2,077$1,307$0$1,859
Deferred Tax$0$0$0$0
Stock-Based Comp.$6,345$0$0$0
Change in WC-$3,873$0-$2,576$0
Other Non-Cash-$20,813$8,410$34,640$18,435
Operating Cash Flow-$36,947-$38,622-$48,901-$48,421
Investing Activities
PP&E Inv.$3,214-$10,763$2,042-$11,497
Net Acquisitions$0$0$1,439$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$4,233-$9,382$1,257-$4,895
Investing Cash Flow$7,446-$20,145$4,739-$16,392
Financing Activities
Debt Repay.$0-$439$0-$147
Stock Issued$0$0$498$50,470
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$17,809$2-$1,393$0
Financing Cash Flow$17,809-$437-$895$50,323
Forex Effect-$115-$161-$1,227$732
Net Chg. in Cash-$33,742$33,742-$46,284-$13,759
Supplemental Information
Beg. Cash$33,742$0$139,392$153,151
End Cash$0$33,742$93,108$139,392
Free Cash Flow-$33,733-$49,385-$46,859-$59,919
Imugene Limited (IUGNF) Financial Statements & Key Stats | AlphaPilot